These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2477198)

  • 1. Further characterisation of the complex containing middle T antigen and pp60.
    Courtneidge SA
    Curr Top Microbiol Immunol; 1989; 144():121-8. PubMed ID: 2477198
    [No Abstract]   [Full Text] [Related]  

  • 2. An 81 kd protein complexed with middle T antigen and pp60c-src: a possible phosphatidylinositol kinase.
    Courtneidge SA; Heber A
    Cell; 1987 Sep; 50(7):1031-7. PubMed ID: 2441879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of tumor formation and cell transformation by polyoma middle T antigen in the absence of Src.
    Thomas JE; Aguzzi A; Soriano P; Wagner EF; Brugge JS
    Oncogene; 1993 Sep; 8(9):2521-9. PubMed ID: 7689725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stoichiometry of cellular and viral components in the polyomavirus middle-T antigen-tyrosine kinase complex.
    Cheng SH; Espino PC; Marshall J; Harvey R; Smith AE
    Mol Cell Biol; 1990 Oct; 10(10):5569-74. PubMed ID: 1697932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of p62c-yes with polyomavirus middle T-antigen mutants correlates with transforming ability.
    Kornbluth S; Cheng SH; Markland W; Fukui Y; Hanafusa H
    J Virol; 1990 Apr; 64(4):1584-9. PubMed ID: 1690822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between the middle T antigen of polyomavirus and host cell proteins.
    Courtneidge SA; Kypta RM; Ulug ET
    Cold Spring Harb Symp Quant Biol; 1988; 53 Pt 1():153-60. PubMed ID: 2855479
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification and characterization of the hamster polyomavirus middle T antigen.
    Courtneidge SA; Goutebroze L; Cartwright A; Heber A; Scherneck S; Feunteun J
    J Virol; 1991 Jun; 65(6):3301-8. PubMed ID: 1709702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenes and phosphatidylinositol turnover.
    Cantley LC; Whitman M; Chahwala S; Fleischman L; Kaplan DR; Schaffhausen BS; Roberts TM
    Ann N Y Acad Sci; 1986; 488():481-90. PubMed ID: 2437850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of a cysteine residue in polyomavirus middle T antigen abolishes interactions with protein phosphatase 2A, pp60c-src, and phosphatidylinositol-3 kinase, activation of c-fos expression, and cellular transformation.
    Glenn GM; Eckhart W
    J Virol; 1993 Apr; 67(4):1945-52. PubMed ID: 7680388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transformation-defective mutants of polyomavirus middle T antigen associate with phosphatidylinositol 3-kinase (PI 3-kinase) but are unable to maintain wild-type levels of PI 3-kinase products in intact cells.
    Ling LE; Druker BJ; Cantley LC; Roberts TM
    J Virol; 1992 Mar; 66(3):1702-8. PubMed ID: 1371171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral T-antigen interactions with cellular proto-oncogene and anti-oncogene products.
    Schreier AA; Gruber J
    J Natl Cancer Inst; 1990 Mar; 82(5):354-60. PubMed ID: 2154582
    [No Abstract]   [Full Text] [Related]  

  • 12. Peptide antibodies to the human c-fyn gene product demonstrate pp59c-fyn is capable of complex formation with the middle-T antigen of polyomavirus.
    Cheng SH; Harvey R; Espino PC; Semba K; Yamamoto T; Toyoshima K; Smith AE
    EMBO J; 1988 Dec; 7(12):3845-55. PubMed ID: 2463167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation.
    Whitman M; Kaplan DR; Schaffhausen B; Cantley L; Roberts TM
    Nature; 1985 May 16-22; 315(6016):239-42. PubMed ID: 2987699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of activation of complexed pp60c-src by the middle T antigen of polyomavirus.
    Cheng SH; Harvey R; Piwnica-Worms H; Espino PC; Roberts TM; Smith AE
    Curr Top Microbiol Immunol; 1989; 144():109-20. PubMed ID: 2477197
    [No Abstract]   [Full Text] [Related]  

  • 15. Transformation by polyoma virus middle T antigen.
    Courtneidge SA
    Cancer Surv; 1986; 5(2):173-82. PubMed ID: 2430702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-directed mutagenesis of polyomavirus middle-T antigen sequences encoding tyrosine 315 and tyrosine 250.
    Markland W; Oostra BA; Harvey R; Markham AF; Colledge WH; Smith AE
    J Virol; 1986 Aug; 59(2):384-91. PubMed ID: 2426465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of two 85 kd proteins that associate with receptor tyrosine kinases, middle-T/pp60c-src complexes, and PI3-kinase.
    Otsu M; Hiles I; Gout I; Fry MJ; Ruiz-Larrea F; Panayotou G; Thompson A; Dhand R; Hsuan J; Totty N
    Cell; 1991 Apr; 65(1):91-104. PubMed ID: 1707345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
    Kamps MP; Sefton BM
    Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphatidylinositol metabolism and polyoma-mediated transformation.
    Kaplan DR; Whitman M; Schaffhausen B; Raptis L; Garcea RL; Pallas D; Roberts TM; Cantley L
    Proc Natl Acad Sci U S A; 1986 Jun; 83(11):3624-8. PubMed ID: 2424008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase C stimulation increases the transforming ability of the polyoma virus middle T antigen.
    Raptis L; Whitfield JF
    Biochem Biophys Res Commun; 1986 Nov; 140(3):1106-12. PubMed ID: 2430571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.